Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × pegfilgrastim × 30 days × Clear all

Phase

Phase 2 5 Phase 1/2 2 Phase NA 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Standard of Care 27 Interviews as Topic 21 Practice Guidelines as Topic 19 Methods 19 Blood Specimen Collection 18 Educational Status 17 Early Intervention, Educational 17 Specimen Handling 16 Surveys and Questionnaires 14 Magnetic Resonance Spectroscopy 13 Radiotherapy 12 Radiosurgery 11 Exercise 11 Exercise Test 8 Patient Navigation 7 Biopsy 7 Drug Therapy 6 Control Groups 6 pembrolizumab 5 X-Rays 5 Therapeutics 5 Physical Therapy Modalities 5 Palliative Care 5 Magnetic Resonance Imaging 5 Genetic Testing 5 Counseling 5 venetoclax 4 Resistance Training 4 Referral and Consultation 4 Proton Therapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05296317 2026-02-19

EMEG-ECDD

Centre Georges Francois Leclerc

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡